Daniel Dicesare, MD
Procedural Dermatology · Rancho Santa Margarita, CANPI 1902859093
Payments from drug & device makers
Across 58 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$288
- Surgenex LLC$150
- Sun Pharmaceutical Industries Inc.$132
- Regeneron Healthcare Solutions, Inc.$99
- AbbVie$84
- Johnson & Johnson$83
- plus $473 from 16 others
What the payments were for
- Food & beverage$1,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $288 |
| Surgenex LLC | 5 | $150 |
| Sun Pharmaceutical Industries Inc. | 6 | $132 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| AbbVie | 4 | $84 |
| Johnson & Johnson | 3 | $83 |
| Pfizer | 2 | $55 |
| Amgen | 2 | $53 |
| Sandoz | 2 | $43 |
| EPI Health, LLC | 2 | $41 |
| Dermira, Inc. | 1 | $41 |
| Incyte Corporation | 2 | $34 |
| Boehringer Ingelheim | 1 | $28 |
| VYNE Pharmaceuticals Inc. | 2 | $27 |
| Sanofi | 1 | $24 |
| Prugen, Inc. Pharmaceuticals | 2 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| Merck | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$1,308 in reported general payments places this provider in the 40th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 35 | $760 |
| Mupirocin | 146 | $758 |
| Ketoconazole | 49 | $645 |
| Clindamycin Phosphate | 21 | $641 |
| Econazole Nitrate | 17 | $250 |
| Triamcinolone Acetonide | 12 | $192 |
| Hydrocortisone | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Rancho Santa Margarita
- Sabrina FabiSan Diego$6.8M
- Natasha MesinkovskaMission Viejo$4M
- Sam Khalifianla Mesa$3.6M
- Mitchel GoldmanSan Diego$1.5M
- Jeanette BlackLos Angeles$492K
- Suzanne KilmerSacramento$475K
- Rebecca FitzgeraldLos Angeles$324K
- Aram KechichianSanta Clarita$300K
- Christopher ZacharyIrvine$269K
- Hrak JalianSanta Monica$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.